Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Oppenheimer Initiates Coverage On Day One Biopharmaceutical with Perform Rating

Oppenheimer Initiates Coverage On Day One Biopharmaceutical with Perform Rating

Oppenheimer analyst Matthew Biegler initiates coverage on Day One Biopharmaceutical (NASDAQ:DAWN) with a Perform rating.

February 3, 2023

1 minute read

Oppenheimer analyst Matthew Biegler initiates coverage on Day One Biopharmaceutical (NASDAQ:DAWN) with a Perform rating.

Morgan Stanley Maintains Equal-Weight on PagerDuty, Raises Price Target to $34

September 2, 7:46 AM

Morgan Stanley analyst Sanjit Singh maintains PagerDuty (NYSE:PD) with a Equal-Weight and raises the price target from $32 to $34.

January 21, 10:54 PM

Tesla Inc (NASDAQ:TSLA) is reportedly sending version 12 of its full self-driving (FSD) software to non-employee drivers, nearly…

May 21, 12:00 PM

10 analysts have expressed a variety of opinions on Intercontinental Exchange (NYSE:ICE) over the past quarter, offering a…

April 19, 10:00 AM

In the preceding three months, 4 analysts have released ratings for Infosys (NYSE:INFY), presenting a wide array of…